To review the epidemiology of HIV in NSW and compare HIV rates in NSW with those of other comparable jurisdictions.
Human immunodeficiency virus (HIV) has been a notifiable disease in New South Wales (NSW) since 1985, shortly after laboratory testing for HIV became available. The purpose of HIV surveillance in NSW is to monitor the epidemiology of HIV infections in NSW to inform the development of better prevention strategies. By 2008, there had been 28 330 diagnoses of HIV in Australia, with 54% occurring in NSW, with the most common risk behaviour being men who have sex with men. 1 Previous studies have shown that, since the late 1990s, NSW, which has stable rates of newly diagnosed HIV in men who have sex with men, is unique compared with other industrialised countries. 2, 3 In this paper we describe the HIV epidemic in NSW and compare NSW rates to those of other Australian jurisdictions and those of comparable international industrialised jurisdictions.
Methods

HIV epidemiology in NSW
Six HIV reference laboratories confirm newly diagnosed HIV infections in NSW. Under the Public Health Act 1991, these laboratories are required to report all confirmed HIV infections to the NSW Department of Health, using a nationally standardised case definition. 4 Laboratories must send a standard notification form with the HIV-positive result to the treating medical practitioner seeking detailed demographical, clinical and HIV risk behaviour information about the patient. The completed form is then forwarded to the NSW Department of Health and the information entered in a secure database.
NSW residents diagnosed with their first positive HIV test in NSW were the subject of this analysis and defined as cases. As a person remains HIV positive for life and can have more than one confirmatory test performed, all new HIV diagnoses were matched against those already on the database. People were excluded from the analysis if they were already on the database, were not NSW residents or reported a previous positive-HIV test outside NSW. A case of newly acquired HIV infection was defined as a person with either a negative or indeterminate HIV antibody test or a seroconversion illness in the 12 months prior to HIV diagnosis. A case of late-diagnosed HIV was defined as having an acquired immune deficiency syndrome (AIDS)-defining illness within three months of HIV diagnosis and/ or a CD4 count less than 200 cells/mm 3 in the absence of a seroconversion illness. Information to determine the stage of diagnosis has only been collected in NSW since 2000 and is thus reported from 2000 onwards.
Risk exposure information was provided by the treating medical practitioner using the notification form. Where more than one risk exposure was reported, a hierarchy of risk was used to designate the case's primary risk exposure -that most strongly associated with transmission of HIV. Homosexually acquired infection was always considered the primary risk exposure if it was reported. High prevalence countries or regions are those where the prevalence of HIV in the population is more than 1% and included Sub Saharan Africa, Thailand, Burma, Cambodia, the Caribbean and Papua New Guinea. Since 1996 the category of heterosexual risk exposure has included cases who have been exposed to these high prevalence countries and other heterosexual exposures, most of which were not further defined. (which includes those individuals who have previously been diagnosed overseas) and rates were calculated using estimated resident populations from the Australian Bureau of Statistics. 6 HIV notifications by number, rate and proportion acquired by men who have sex with men were also sought from comparable international jurisdictions that had data publicly available from 2000, including Canada, 7 the United Kingdom (UK), 8 New Zealand, 9 the European Union countries, 10 the United States of America including San Francisco 11 and New York. 12 Rates for the USA only included those from states with confidential name-based HIV infection reporting for 2004 to 2007. [13] [14] [15] [16] Where rates were not provided in these reports, they were calculated using reported population estimates.
National and international comparisons
17,18 The case definitions used in these jurisdictions all include laboratory confirmation of HIV infection.
Results
Since 1984, 15 106 NSW residents have been newly diagnosed in NSW. The rate of newly diagnosed HIV infections peaked in NSW in 1987 at 29.1 per 100 000 population ( Figure 1 ). Since then the notification rate has decreased significantly and has been stable since 2000 with an average annual rate of 5.6 per 100 000 population. there have been no reported cases of HIV transmission through the receipt of a blood or tissue product, except for one case where the exposure occurred in the early 1980s. Vertical transmission (from mother to child) was reported as the risk exposure for an average of two cases per year since the beginning of the epidemic, with the highest number reported in 1991 at five cases. Where country of birth was reported (n ¼ 29), most cases acquired through vertical transmission (76%) were born in Australia. (Figure 3 ).
Risk exposures in NSW
International comparisons
The rate of people newly diagnosed with HIV since 2000 in NSW and the rest of Australia was lower than in other similarly developed jurisdictions reviewed, except for New Zealand. Like NSW, the rates of newly diagnosed HIV in most of these other jurisdictions have remained stable over the last few years (Figure 4 ), except in New York City and San Francisco, where the rates, although much higher than NSW, have decreased ( Figure 5 ).
Discussion
NSW has consistently had the highest rates of newly diagnosed HIV in Australia since the beginning of the HIV epidemic in the early 1980s. The rate of newly diagnosed HIV has stabilised in the last decade in NSW, which was not observed in other Australian jurisdictions until more recent years. Notification rates nationally have converged. 19 The apparent decline in NSW in 2008 was likely due in part to improved identification of people who had previously tested positive for HIV infection. The NSW epidemic has occurred predominately in men who have sex with men, although there has been a modest increase in the number of cases reporting heterosexual acquisition since the mid 1990s. Acquisition through injecting drug use has been minimal in the latter half of the epidemic with the other risk exposures, such as blood products, rarely occurring since early in the epidemic. NSW has lower rates of newly diagnosed HIV than other comparable international jurisdictions except New Zealand, and is not alone in reporting stable rates in the last decade, particularly for men who have sex with men. 2, 3 Canada reported that a fifth of its cases were exposed through injecting drug use; the peak number of HIV notifications for men who have sex with men, 581, in 2004 has decreased each year to 515 for 2007. 7 San Francisco reported similar proportions of men who have sex with men as NSW of between 62% and 70% each year between 2002 and 2008; the decline in the total rate of HIV over the last decade corresponds to a decrease in the rate of HIV in men who have sex with men. 11 New York, for the three years of data available, had similar annual numbers of cases of HIV diagnosed in men who have sex with men. 12 In contrast, in the UK, half the HIV cases are reported as being heterosexually acquired, mostly in migrants from Sub-Saharan Africa. There are also reports of increasing numbers of cases occurring among men who have sex with men.
20 New Zealand and the European Union countries also reported higher proportions of heterosexual acquisition compared with NSW, and also a doubling of the number of men who have sex with men since 2000. 10, 17 The use of notification data for reporting the HIV epidemic has its limitations as these data neither represent the total number of people with HIV infection (prevalence) or the number of people with newly acquired infection each year (incidence). Notification data reflect only those who have been tested and diagnosed with HIV. Given that HIV is a chronic infection with a long latent period and that routine laboratory testing does not distinguish newly acquired cases of HIV from other cases it is impossible to accurately determine the timing of disease acquisition for many newly diagnosed infections. Newly diagnosed people who test more frequently are more likely to be identified as newly acquired thus comparisons between risk behaviours and countries with different testing practices should be made with caution. 
